Kåre Schultz
Kåre Schultz | |
---|---|
Kåre Schultz in 2017 | |
Born | 21 May 1961 |
Nationality | Danish |
Alma mater | University of Copenhagen |
Occupation | CEO of Teva Pharmaceutical Industries |
Spouse(s) | Randi Mondorf |
Children | 3 |
Kåre Schultz (21 May 1961) is a Danish business executive. He was appointed to new chief executive officer of Teva Pharmaceutical Industries in September 2017.
Career
Schultz has a Cand.polit. degree from the University of Copenhagen in 1987. He initially worked as a consultant for Andersen Consulting in London and for McKinsey & Company in Copenhagen.[1]
He began to work for Novo Nordisk in 1989. He was appointed as executive vice president (staff and quality) in 2000, and became COO in 2002. In 2015, he was appointed as president and vice CEO.
In April 2015, Schultz left Novo Nordisk to assume a position as CEO of Lundbeck.[2]
In September 2017, he was appointed as the new CEO of Teva Pharmaceutical Industries.[3]
He was the chairman of Royal Unibrew from 2010 until the end of December 2017.[4] He has also been a member of Lego's board of directors since 2007.[5]
Personal life
Schultz is married to Randi Mondorf. They have three children.[6]
References
- ↑ "BLÅ BOG: Hvem er Kåre Schultz". fyns.dk (in Danish). Retrieved 12 September 2017.
- ↑ "Kåre Schultz bliver ny topchef i Lundbeck". Dagbladet Børsen (in Danish). Retrieved 12 September 2017.
- ↑ "Teva Appoints New Chief Executive After Months of Speculation". The Wall Street Journal. Retrieved 12 September 2017.
- ↑ "Changes to the Board of Directors of Royal Unibrew A/S". Royal Unibrew. Retrieved 2 February 2018.
- ↑ "Kåre Schultz". Lego. Retrieved 2 February 2018.
- ↑ "Novo Nordisks festglade kronprins". Berlingske (in Danish). Retrieved 12 September 2017.